The strong revenue growth is mirrored in the share price gai...
The strong revenue growth is mirrored in the share price gain. Despite the strong run, top performers like Krystal Biotech can continue winning for decades. The stock's recent performance improvement may suggest real business momentum.
Investing in Krystal Biotech (NASDAQ:KRYS) Five Years Ago Would Have Delivered You a 389% Gain
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment